Biomarker News and Research

RSS

A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular marker and signature molecule.

Blood pressure self-monitoring can help patients with hypertension to stick with exercise program

Using blood pressure self-monitoring is an effective way to empower patients with hypertension to stick with an exercise program, according to a first-of-its-kind study conducted by a multidisciplinary team of UConn researchers in collaboration with Hartford Hospital.

1 Jul 2019

ANCON Medical discusses how NBT technology is better at providing accurate cancer diagnosis

Cancers cells now have a powerful adversary called 'magnetic hyperthermia' and it consists of clusters of magnetic nanoparticles.

1 Jul 2019

Researchers attempt to solve PTSD puzzle

A team of Penn State and University of Puerto Rico School of Medicine researchers is attempting to answer a question that has long puzzled experts: Why do some individuals suffer post-traumatic stress disorder (PTSD) after experiencing trauma, and others do not?

29 Jun 2019

Protein linked to malignant melanoma

Almost 300,000 people worldwide develop malignant melanoma each year. The disease is the most serious form of skin cancer and the number of cases reported annually is increasing, making skin cancer one of Sweden's most common forms of cancer.

28 Jun 2019

Extremely strenuous exercise can overload the heart without increasing cardiac risk

Researchers have found no evidence of elevated cardiac risk in runners who completed a 24-hour ultramarathon (24UM), despite the transient elevation of blood biomarkers that measure cardiac health.

28 Jun 2019

Quanterix announces Kevin Hrusovsky, Chairman and Chief Executive Officer, and Founder of Powering Precision Health, as EY Entrepreneur Of The Year 2019 Award Winner in New England

Quanterix, announce Chairman and CEO of Quanterix, and Founder of Powering Precision Health, has been recognized with the Entrepreneur Of The Year 2019 Award.

From Quanterix 28 Jun 2019

Promega UK publishes 2019 Corporate Responsibility Report of sustainable practices and outcomes

Promega announce publication of its annual Corporate Responsibility Report of sustainable practices and resulting trends through the previous year.

From Promega Corporation 28 Jun 2019

Sleep quality could be indicator for later Alzheimer’s disease finds study

A new study from the researchers at the University of California, Berkeley has shown that progressively declining quality of sleep among those in their 50s and 60s could be indicative of protein tangles within their brains that could lead to later development of Alzheimer’s disease.

28 Jun 2019

Sleep decline in one's 50s, 60s increases risk of Alzheimer's disease

People who report a declining quality of sleep as they age from their 50s to their 60s have more protein tangles in their brain, putting them at higher risk of developing Alzheimer's disease later in life, according to a new study by psychologists at the University of California, Berkeley.

27 Jun 2019

A metabolic intermediate in the uronic acid pathway impairs lung cancer metastasis

In a study published online in Nature on June 26, research teams led by Dr. YANG Weiwei at the Institute of Biochemistry and Cell Biology of the Chinese Academy of Sciences and Dr. LI Guohui from the Dalian Institute of Chemical Physics of CAS reported a new function of uridine diphosphate glucose (UDP-glucose), a metabolic intermediate in the uronic acid pathway: It impairs lung cancer metastasis by accelerating SNAI1 mRNA decay.

27 Jun 2019

New prostate cancer test could bring an end to unnecessary biopsies

Researchers have developed a new urine test to diagnose aggressive forms of prostate cancer, which could mean an end to the unnecessary treatment of men with non-aggressive cancers.

26 Jun 2019

Quanterix announces agreement to acquire UmanDiagnostics, world’s leading neurofilament light (Nf-l) antibody supplier

Quanterix announce agreement to acquire privately held UmanDiagnostics AB for $22.5 million.

From Quanterix 26 Jun 2019

Higher levels of doublets in flow cytometry indicate tuberculosis or dengue fever

Sorting through individual immune cells is a handy way to see how the body responds to disease. For years, researchers around the world have used a technique called flow cytometry to separate different types of immune cells, such as T cells, B cells and monocytes.

26 Jun 2019

Researchers discover early biomarker for degenerative neurologic disease

Researchers have discovered a novel radioligand that can effectively differentiate progressive supranuclear palsy (PSP) from similar brain disorders, allowing for earlier and more reliable diagnosis of the disease.

24 Jun 2019

Suppressing amygdala molecule enables faster recovery from PTSD symptoms

Fight or flight, panic, trembling: Our brains are wired to ensure we respond instantly to fear. While that fear response may save our lives in the dangerous moment, at times people stay on high alert long after the threat has passed, and develop post-traumatic stress disorder.

20 Jun 2019

New blood test offers more precise diagnostics of ovarian cancer

The majority of women who undergo surgery for suspected ovarian cancer do not have cancer. A novel blood test developed by researchers at Uppsala University and the Sahlgrenska Academy, University of Gothenburg, in Sweden, now offers the possibility of more precise diagnostics without the need for surgery.

20 Jun 2019

Investigational drug for treatment of sickle cell disease shows early promise in clinical trials

An investigational drug for the treatment of sickle cell disease is showing early promise in clinical trials for impacting biomarkers of the disease in patients, reported UConn School of Medicine researchers at the European Hematology Association Congress in Amsterdam this week.

20 Jun 2019

New ZetaView QUATT enhances nanoparticle analysis specificity

Analytik has launched the next generation ZetaView QUATT, with a multi-wavelength video tracking microscope for rapid analysis of size, concentration, fluorescence, electrophoretic mobility and sub-populations of individual nanoparticles.

From Analytik Ltd 19 Jun 2019

Invitation to attend Microbiome Movement – Drug Development & Nutrition Summit in Singapore

As the Program Director of the Microbiome Movement, I would like to formally invite you to join us an esteemed member of the delegation for the inaugural Microbiome Movement – Drug Development & Nutrition Summit taking place September 17-18 in Singapore.

From The Microbiome Movement 19 Jun 2019

Study links high number of copies of chromosomal region to chemotherapeutic drug resistance

Researchers at the Bellvitge Biomedical Research Institute, with the participation of collaborators from the Baylor College of Medicine and the University Institute of Oncology of Asturias, publish today in Cancer Research a study where they relate the high number of copies of a chromosomal region with the appearance of resistance to a chemotherapeutic drug.

19 Jun 2019

Biomarker News and Research

Further Reading

Blood pressure self-monitoring can help patients with hypertension to stick with exercise program

ANCON Medical discusses how NBT technology is better at providing accurate cancer diagnosis

Researchers attempt to solve PTSD puzzle

Protein linked to malignant melanoma

Extremely strenuous exercise can overload the heart without increasing cardiac risk

Quanterix announces Kevin Hrusovsky, Chairman and Chief Executive Officer, and Founder of Powering Precision Health, as EY Entrepreneur Of The Year 2019 Award Winner in New England

Promega UK publishes 2019 Corporate Responsibility Report of sustainable practices and outcomes

Sleep quality could be indicator for later Alzheimer’s disease finds study

Sleep decline in one's 50s, 60s increases risk of Alzheimer's disease

A metabolic intermediate in the uronic acid pathway impairs lung cancer metastasis

New prostate cancer test could bring an end to unnecessary biopsies

Quanterix announces agreement to acquire UmanDiagnostics, world’s leading neurofilament light (Nf-l) antibody supplier

Higher levels of doublets in flow cytometry indicate tuberculosis or dengue fever

Researchers discover early biomarker for degenerative neurologic disease

Suppressing amygdala molecule enables faster recovery from PTSD symptoms

New blood test offers more precise diagnostics of ovarian cancer

Investigational drug for treatment of sickle cell disease shows early promise in clinical trials

New ZetaView QUATT enhances nanoparticle analysis specificity

Invitation to attend Microbiome Movement – Drug Development & Nutrition Summit in Singapore

Study links high number of copies of chromosomal region to chemotherapeutic drug resistance

Event guide: World Clinical Biomarkers & CDx Summit Japan eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo